Drug price controls have populist appeal, but patients are the ones they would hurt the most bit.ly/1X3e742 http://t.co/ulXuGHLSld—
Manhattan Institute (@ManhattanInst) October 17, 2015
@BernieSanders @HillaryClinton drug price controls will shorten lives
21 Oct 2015 Leave a comment
in applied price theory, applied welfare economics, economics of regulation, entrepreneurship, health economics, politics - USA Tags: 2016 presidential election, creative destruction, drug lags, entrepreneurial alertness, innovations, intellectual property, patents and copyright, price controls
Recent Comments